Replies to post #7360 on Ayala Pharmaceuticals Inc (ADXS)

[fbg0316]

Agreed, we should be valuate at least $20/$800 million cap at this stage. I too think we'll see a catalyst to get us there by year-end (solid initial combo data and/or a partnership with Astra Zeneca).